Similar articles

• [Chemotherapy of solid tumors as benefit or harm to the patient].

  Gröhn P. Gröhn P. Duodecim. 1986;102(22):1662-7. Duodecim. 1986. PMID: 3803256 Finnish. No abstract available.
• The heart of the matter.

  Portera CC, Swain SM. Portera CC, et al. J Clin Oncol. 2007 Sep 1;25(25):3794-6. doi: 10.1200/JCO.2007.11.9537. Epub 2007 Jul 30. J Clin Oncol. 2007. PMID: 17664459 No abstract available.
• Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.

  Chen C, Heusch A, Donner B, Janssen G, Göbel U, Schmidt KG. Chen C, et al. Klin Padiatr. 2009 May-Jun;221(3):162-6. doi: 10.1055/s-0029-120722. Epub 2009 May 12. Klin Padiatr. 2009. PMID: 19437364
• Antitumor antibiotics, epipodophyllotoxins, and vinca alkaloids: clinical developments.

  Brenner DE. Brenner DE. Curr Opin Oncol. 1990 Dec;2(6):1115-8. doi: 10.1097/00001622-199012000-00015. Curr Opin Oncol. 1990. PMID: 2099842 Review. No abstract available.
• Multidrug resistance in the laboratory and clinic.

  Kane SE, Gottesman MM. Kane SE, et al. Cancer Cells. 1989 Sep;1(1):33-6. Cancer Cells. 1989. PMID: 2701361 Review. No abstract available.